Navigation Links
FierceBiotech Names Enanta Pharmaceuticals, Inc. a Fierce 15 Winner
Date:9/19/2012

WATERTOWN, Mass., Sept. 19, 2012 /PRNewswire/ -- Enanta Pharmaceuticals, Inc., a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, announced today that Enanta was named by FierceBiotech as one of 2012's Fierce 15.

The annual award, which was announced today during the BioPharm America Conference at the Westin Boston Waterfront Hotel in Boston, was created by FierceBiotech to recognize 15 promising private biotech companies selected from around the world for their potential to have impact on the treatment of human diseases. This is FierceBiotech's tenth annual Fierce 15 selection. Every year, FierceBiotech evaluates hundreds of private companies for the list, which is based on a variety of factors including the strength of each company's technology, partnerships, venture funding and a competitive market position.

"While biotechs have been scrambling in the race to the market with an interferon-free treatment for hepatitis C, Enanta has been building its pipeline of compounds for use in HCV combination therapies," said FierceBiotech Editor John Carroll. "It's struck key partnerships with Abbott and Novartis and has additional unpartnered programs."

"We are honored to be chosen as one of the Fierce 15 and recognized for our work in the infectious disease field—specifically, our work in multiple HCV drug classes designed for use against the hepatitis C virus," commented Jay R. Luly, Ph.D., President and Chief Executive Officer of Enanta. "Our goal of providing patients with innovative therapies that are safer and more effective than current treatments is what motivates our employees every day."

About Enanta

Enanta Pharmaceuticals is a research and development-focused biotechnology company that uses its robust chemistry-driven approach and drug discovery capabilities to create best in class small molecule drugs in the infectious disease field. Enanta is discovering and developing novel inhibitors designed for use against the hepatitis C virus (HCV). These inhibitors include members of the direct acting antiviral (DAA) inhibitor classes – protease (partnered with Abbott), NS5A (partnered with Novartis) and nucleotide polymerase – as well as a host targeted antiviral (HTA) inhibitor class targeted against cyclophilin. Additionally, the company has created a new class of antibiotics, called Bicyclolides, for the treatment of multi-drug resistant bacteria, with a current focus on developing intravenous and oral treatments for hospital and community MRSA infections. Enanta is a privately-held company headquartered in Watertown, Massachusetts. Enanta's news releases and other information are available on the company's website at www.enanta.com.

About FierceBiotech

FierceBiotech is the biotech industry's daily monitor - a free email newsletter and web resource providing the latest biotech news, articles, and resources related to clinical trials, drug discovery, FDA approval and regulation, biotech company deals and more. More than 100,000 top biotech and pharma professionals rely on FierceBiotech for an insider briefing on the day's top stories. Sign up is free at www.fiercebiotech.com.

Investor Contact
Carol Miceli
Enanta Pharmaceuticals, Inc.
617-607-0710
cmiceli@enanta.com

Media Contact
Kari Watson
MacDougall Biomedical Communications
781-235-3060
kwatson@macbiocom.com


'/>"/>
SOURCE Enanta Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Amgen Names Ray Jordan Senior Vice President, Corporate Affairs
2. Islet Sciences Names Richard A. Franco, Sr. to its Board of Directors
3. Elsevier / MEDai Names Dr. Peter Edelstein as Chief Medical Officer and Dr. Gerald Osband as Director of Product Strategy
4. PharmaVOICE Names Four inVentiv Health Associates Among "100 Most Inspiring" Leaders in Healthcare
5. Lloyd Library and Museum Names ABCs Blumenthal to New Honorary Advisory Board
6. Ethical Corporation Names Life Technologies First CSO Sustainability Executive of the Year
7. Triple-S Management Corporation Announces the Retirement of Socorro Rivas-Rodriguez; Names Pablo Almodovar Scalley as Successor
8. 23andMe Names Andy Page to Board of Directors
9. Biggest Names in Pharmaceutical, Healthcare Industry to Gather for Groundbreaking Event in Parsippany, New Jersey on September 11-12, 2012
10. BioMotiv Launches Novel Drug Development Operation, Names Leadership Team
11. Sapphire Energy Names New Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... ... February 08, 2016 , ... Net-Translators, ... today the launch of its revamped and improved website. In an on-going effort ... the redesigned website will better communicate how the company designs and delivers thorough, ...
(Date:2/9/2016)... ... February 09, 2016 , ... The publishing ... Open Access publishing is one of the popular publication models that has received ... journals and 3000+ International Conferences across the globe, OMICS International ...
(Date:2/9/2016)... , February 9, 2016 Web ... paper and protect IP   E-WorkBook 10 ... rolled out in Germany early this ... valuable IP. Users will be able to search for information ... as part of the application, to boost collaboration and productivity. ...
(Date:2/8/2016)... /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") ... clean technology companies in the TSX Venture 50 TM . ... on the TSX Venture Exchange, in each of five major ... & life sciences, diversified industries and technology – based ... on investment, market cap growth, trading volume and analyst coverage. ...
Breaking Biology Technology:
(Date:2/2/2016)... , Feb. 2, 2016  BioMEMS ... are primarily focused on medical screening and ... point-of-care parameters. Wearable devices that facilitate and ... freedom of movement are being bolstered through ... human biomedical signal acquisition coupled with wireless ...
(Date:2/2/2016)... , Feb. 2, 2016   Parabon NanoLabs ... the U.S. Army Research Office and the Defense ... and sensitivity of the company,s Snapshot Kinship ... Mission and, more generally, defense-related DNA forensics.  Although ... capabilities (predicting appearance and ancestry from DNA evidence), ...
(Date:2/1/2016)... wallet ( www.wocketwallet.com ) announces the launch of a new video featuring ... Las Vegas , where Joey appeared at the Wocket booth ... , where Joey appeared at the Wocket booth to meet and ... at the Consumer Electronics Show (CES2016) in Las Vegas ... fans. --> --> The video ...
Breaking Biology News(10 mins):